USES OF ANTI-CTLA-4 ANTIBODIES
A találmány tárgyát CTLA-4 elleni antitestek alkalmazásai, valamintCTLA-4 elleni antitestet tartalmazó, rákos megbetegedések kezeléséreszolgáló gyógyászati készítmények képezik, mely antitestek humángénből származó aminosav-szekvenciákat tartalmaznak. Ó Anti-CTLA-4 antibodies, particularly human ant...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; hun |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HANSON, DOUGLAS CHARLES MUELLER, EILEEN ELLIOTT |
| description | A találmány tárgyát CTLA-4 elleni antitestek alkalmazásai, valamintCTLA-4 elleni antitestet tartalmazó, rákos megbetegedések kezeléséreszolgáló gyógyászati készítmények képezik, mely antitestek humángénből származó aminosav-szekvenciákat tartalmaznak. Ó
Anti-CTLA-4 antibodies, particularly human anti-CTLA-4 antibodies such as those having amino acid sequences of antibodies 3.1.1, 4.1.1, 4.8.1, 4.10.2, 4.13.1, 4.14.3, 6.1.1, 112.1, 11.6.1, 11.7.1, 12.3.1.1, and 12.9.1.1, are used in the treatment of certain cancers. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUP0201737A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUP0201737A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUP0201737A23</originalsourceid><addsrcrecordid>eNrjZJALDXYNVvB3U3D0C_HUdQ7xcdQ1AbOd_F08XYN5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8R2iAgZGBobmxuaORMTFqAJUBIT4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USES OF ANTI-CTLA-4 ANTIBODIES</title><source>esp@cenet</source><creator>HANSON, DOUGLAS CHARLES ; MUELLER, EILEEN ELLIOTT</creator><creatorcontrib>HANSON, DOUGLAS CHARLES ; MUELLER, EILEEN ELLIOTT</creatorcontrib><description>A találmány tárgyát CTLA-4 elleni antitestek alkalmazásai, valamintCTLA-4 elleni antitestet tartalmazó, rákos megbetegedések kezeléséreszolgáló gyógyászati készítmények képezik, mely antitestek humángénből származó aminosav-szekvenciákat tartalmaznak. Ó
Anti-CTLA-4 antibodies, particularly human anti-CTLA-4 antibodies such as those having amino acid sequences of antibodies 3.1.1, 4.1.1, 4.8.1, 4.10.2, 4.13.1, 4.14.3, 6.1.1, 112.1, 11.6.1, 11.7.1, 12.3.1.1, and 12.9.1.1, are used in the treatment of certain cancers.</description><edition>7</edition><language>eng ; hun</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030228&DB=EPODOC&CC=HU&NR=P0201737A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030228&DB=EPODOC&CC=HU&NR=P0201737A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HANSON, DOUGLAS CHARLES</creatorcontrib><creatorcontrib>MUELLER, EILEEN ELLIOTT</creatorcontrib><title>USES OF ANTI-CTLA-4 ANTIBODIES</title><description>A találmány tárgyát CTLA-4 elleni antitestek alkalmazásai, valamintCTLA-4 elleni antitestet tartalmazó, rákos megbetegedések kezeléséreszolgáló gyógyászati készítmények képezik, mely antitestek humángénből származó aminosav-szekvenciákat tartalmaznak. Ó
Anti-CTLA-4 antibodies, particularly human anti-CTLA-4 antibodies such as those having amino acid sequences of antibodies 3.1.1, 4.1.1, 4.8.1, 4.10.2, 4.13.1, 4.14.3, 6.1.1, 112.1, 11.6.1, 11.7.1, 12.3.1.1, and 12.9.1.1, are used in the treatment of certain cancers.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJALDXYNVvB3U3D0C_HUdQ7xcdQ1AbOd_F08XYN5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8R2iAgZGBobmxuaORMTFqAJUBIT4</recordid><startdate>20030228</startdate><enddate>20030228</enddate><creator>HANSON, DOUGLAS CHARLES</creator><creator>MUELLER, EILEEN ELLIOTT</creator><scope>EVB</scope></search><sort><creationdate>20030228</creationdate><title>USES OF ANTI-CTLA-4 ANTIBODIES</title><author>HANSON, DOUGLAS CHARLES ; MUELLER, EILEEN ELLIOTT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUP0201737A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2003</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HANSON, DOUGLAS CHARLES</creatorcontrib><creatorcontrib>MUELLER, EILEEN ELLIOTT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HANSON, DOUGLAS CHARLES</au><au>MUELLER, EILEEN ELLIOTT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USES OF ANTI-CTLA-4 ANTIBODIES</title><date>2003-02-28</date><risdate>2003</risdate><abstract>A találmány tárgyát CTLA-4 elleni antitestek alkalmazásai, valamintCTLA-4 elleni antitestet tartalmazó, rákos megbetegedések kezeléséreszolgáló gyógyászati készítmények képezik, mely antitestek humángénből származó aminosav-szekvenciákat tartalmaznak. Ó
Anti-CTLA-4 antibodies, particularly human anti-CTLA-4 antibodies such as those having amino acid sequences of antibodies 3.1.1, 4.1.1, 4.8.1, 4.10.2, 4.13.1, 4.14.3, 6.1.1, 112.1, 11.6.1, 11.7.1, 12.3.1.1, and 12.9.1.1, are used in the treatment of certain cancers.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; hun |
| recordid | cdi_epo_espacenet_HUP0201737A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | USES OF ANTI-CTLA-4 ANTIBODIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T12%3A47%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HANSON,%20DOUGLAS%20CHARLES&rft.date=2003-02-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUP0201737A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |